Amy S. Paller, MD, chair of dermatology, Feinberg School of Medicine at Northwestern University, discusses aspects of this year's American Academy of Dermatology (AAD) conference she is most excited about.
This content was produced independently by The American Journal of Managed Care® and is not endorsed by the American Academy of Dermatology.
The American Academy of Dermatology (AAD) meeting is always a great opportunity to network with colleagues and collaborate with new people, says Amy S. Paller, MD, chair of dermatology, Feinberg School of Medicine at Northwestern University.
Paller is set to present a handful of sessions, including 2 late-breaking sessions, a session on covering systemics for pediatric patients, and another session on advances in comorbidities and therapy in atopic dermatitis and psoriasis.
Transcript
What are you looking forward to most at this year's AAD Annual Meeting?
I always look forward to the AAD meetings because it's a chance to really catch up on what's the latest news. In my areas of specialty, the genetic skin diseases and inflammatory skin diseases, there's so much to learn from my colleagues who, as I am, are doing cutting-edge research and bringing new medications to our patients, but also new understanding of diseases. I'm looking forward to hearing that. I'm also looking forward to networking, because the academy is such a great opportunity to catch up with friends and make new collaborations.
What do you hope attendees take away from the meeting sessions?
I'll be presenting in several sessions, but probably most importantly is to hear tips about how we may manage patients in practice [in ways] they may not have thought of before, and very importantly, to update them on the latest therapies that may be available for treating inflammatory skin diseases.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More